Strides Arcolab’s specialties arm inks pact with Malaysian Bio-XCell Ecosystem

29 Jun 2011 Evaluate

Stride Arcolab’s specialties subsidiary Agila Specialists (Malaysia) and Malaysian Bio-XCell, the investment arm of Malaysian Biotechnology Corporation, has exchanged agreement for the establishment of a customized facility to manufacture biopharmaceuticals and sterile injectables in the Bio-Xcell ecosystem in Johor, Malaysia.

The agreement was exchanged by Adam Levitt, CEO-Americas of Strides Arcolab and Raja Ridzwa Raja Abdul Aziz, CEO of Bio-XCell in the presence of Tan Myhyiddin Yassin, Deputy Price Minister of Malaysia during the Bio Intentional Convention 2011 in Washington DC.

The project will be built by Bio-Xcell to the design requirements of Strides and will be leased out to Strides on a long-term basis. The lease rentals are applicable from the date of commercialization which supports the biotech strategy of Strides where there is a long gestation period from development to commercialization.

Strides Arcolab is a global pharmaceuticals company headquartered in Banglore, India that develops and manufactures wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

684.30 -15.00 (-2.15%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.